One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids

• Status: Completed
• Trial end date: 2009-07-01

Summary

The primary objective of this study is to evaluate efficacy of AZD1981 in uncontrolled asthmatic patients on maintenance inhaled glucocorticosteroids.

• Phase: Phase 2

Details

• Lead Sponsor: AstraZeneca